Articles

< Previous         Next >  
Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes Free
Deepak Jain1,†, Ruchi Jain1,†, Daniel Eberhard1, Jan Eglinger1,2, Marco Bugliani3, Lorenzo Piemonti4, Piero Marchetti3, and Eckhard Lammert1,2,*
1Institute of Metabolic Physiology, Heinrich-Heine University, D-40225 Düsseldorf, Germany
2Paul Langerhans Group for Beta Cell Biology, German Diabetes Center (DDZ), D-40225 Düsseldorf, Germany
3Metabolic Unit, Department of Endocrinology and Metabolism, Cisanello Hospital, 56100 Pisa, Italy
4Laboratory of Experimental Surgery, Surgical Department, San Raffaele Scientific Institute, 20132 Milano, Italy *Correspondence to:Eckhard Lammert, E-mail: lammert@uni-duesseldorf.de
J Mol Cell Biol, Volume 4, Issue 4, August 2012, 221-230,  https://doi.org/10.1093/jmcb/mjs025
Keyword: diabetes, pancreatic islets, DJ-1, mitochondria
Elderly patients often suffer from multiple age-related diseases. Here we show that the expression of DJ-1, an antioxidant protein with reduced expression in the central nervous system of patients with Parkinson's disease, is reduced in pancreatic islets of patients with type 2 diabetes mellitus (T2DM). In contrast, under non-diabetic conditions, DJ-1 expression increases in mouse and human islets during aging. In mouse islets, we show that DJ-1 prevents an increase in reactive oxygen species levels as the mice age. This antioxidant function preserves mitochondrial integrity and physiology, prerequisites for glucose-stimulated insulin secretion. Accordingly, DJ-1-deficient mice develop glucose intolerance and reduced β cell area as they age or gain weight. Our data suggest that DJ-1 is more generally involved in age- and lifestyle-related human diseases and show for the first time that DJ-1 plays a key role in glucose homeostasis and might serve as a novel drug target for T2DM.